Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain SUPN message board posts where the ticker symbol SUPN has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest SUPN SEC Filings

Filings Format Description Filing Date File/Film Number
8-K  Documents Current report, items 8.01 and 9.01
Acc-no: 0001104659-17-067411 (34 Act)  Size: 44 KB
2017-11-09 001-35518
171191306
8-K/A  Documents [Amend] Current report, item 5.07
Acc-no: 0001104659-17-067359 (34 Act)  Size: 27 KB
2017-11-09 001-35518
171190716
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001104659-17-067057 (34 Act)  Size: 5 MB
2017-11-09 001-35518
171187678
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001104659-17-066379 (34 Act)  Size: 261 KB
2017-11-07 001-35518
171180732
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001104659-17-063584 (34 Act)  Size: 45 KB
2017-10-24 001-35518
171151391
UPLOAD  Documents [Cover]SEC-generated letter
Acc-no: 0000000000-17-036980 Size: 134 KB
2017-10-18
CORRESP  Documents [Cover]Correspondence
Acc-no: 0001104659-17-060905 Size: 213 KB
2017-10-04
8-K  Documents Current report, items 8.01 and 9.01
Acc-no: 0001104659-17-058091 (34 Act)  Size: 50 KB
2017-09-20 001-35518
171094311
UPLOAD  Documents [Cover]SEC-generated letter
Acc-no: 0000000000-17-033372 Size: 144 KB
2017-09-20
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001104659-17-056611 Size: 24 KB
2017-09-11
More SUPN SEC Filings


Related news from
Wed, 13 Dec 2017
08:00:00 +0000
Stocks Showing Improved Relative Strength: Supernus Pharmaceuticals
Supernus Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Sun, 10 Dec 2017
16:02:26 +0000
Best-In-Class NasdaqGM Growth Stocks
Investors seeking to increase their exposure to growth should consider companies such as Supernus Pharmaceuticals and Sandy Spring Bancorp. Analysts are generally optimistic about the future of these stocks, basedRead More...
Thu, 30 Nov 2017
13:07:20 +0000
See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc NASDAQ NMS:SUPN
Fri, 17 Nov 2017
19:43:00 +0000
Why Biotech Sage Therapeutics Is Overvalued
Sage's stock soared after it reported promising clinical results for its postpartum depression drug.
Fri, 10 Nov 2017
01:56:04 +0000
Edited Transcript of SUPN earnings conference call or presentation 7-Nov-17 2:00pm GMT
Q3 2017 Supernus Pharmaceuticals Inc Earnings Call
Fri, 10 Nov 2017
00:16:00 +0000
Cramer's lightning round: You don't want to touch Pandora...
Jim Cramer zoomed through his take on callers' favorite stocks, including the stock of a music streaming service.
Wed, 08 Nov 2017
21:30:00 +0000
Supernus to Present at Three November Healthcare Conferences
ROCKVILLE, Md., Nov. 08, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ...
Tue, 07 Nov 2017
21:15:00 +0000
Why Supernus Pharmaceuticals Inc. Is Having a Rather Non-Super Day
Despite Supernus' strong third-quarter earnings report, two possible concerns send the stock tumbling.
Tue, 07 Nov 2017
12:20:00 +0000
Supernus Pharmaceuticals, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 9:00 ...
Tue, 07 Nov 2017
12:01:22 +0000
These Five 95+ Composite Rating Stocks Are Moving On Earnings, Deals; S&P 500 Futures
Apple supplier Skyworks, Microchip Technology and Supernus Pharmaceuticals fell overnight despite beating earnings views. Google and Salesforce rose on a new alliance. All five stocks have 95+ Composite Ratings.
Mon, 06 Nov 2017
22:49:49 +0000
Supernus tops Street 3Q forecasts
The Rockville, Maryland-based company said it had profit of 29 cents per share. The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was ...
Mon, 06 Nov 2017
22:29:17 +0000
Supernus Pharma Tops Third-Quarter Sales, Earnings Views
Supernus Pharmaceuticals reported adjusted income of 29 cents per share on revenue of $80.4 million for the third quarter.
Mon, 06 Nov 2017
22:00:00 +0000
Supernus Announces Third Quarter 2017 Financial Results
Third quarter net product sales were $78.1 million, a 40% increase over 2016. Third quarter operating income was $22.3 million, a 13% increase over 2016. Initiated Phase III clinical trials for SPN-812. ...
Mon, 30 Oct 2017
16:16:59 +0000
ETFs with exposure to Supernus Pharmaceuticals, Inc. : October 30, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more <b>(Read more...)</b>
Thu, 26 Oct 2017
13:10:40 +0000
Analysts’ Latest Recommendations for AbbVie
In October 2017, AbbVie (ABBV) and Harpoon Therapeutics entered into an immune-oncology research collaboration.
Tue, 24 Oct 2017
20:15:00 +0000
Supernus to Host Third Quarter 2017 Earnings Conference Call
ROCKVILLE, Md., Oct. 24, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ...
Fri, 20 Oct 2017
21:39:00 +0000
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Supernus Pharmaceuticals, Inc.
Levi & Korsinsky announces it has commenced an investigation of Supernus Pharmaceuticals, Inc. concerning possible violations of federal securities laws.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This site is a gem, and based on the posts by many members and my personal experience it is a site for learning, sharing and especially making money." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards